Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits.
Subthalamic nucleus beta oscillations and sleep disorders in Parkinson's disease: A new perspective on deep brain stimulation regulation mechanisms and circuits.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Wuhan, CN · Author affiliation
Department of Neurosurgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.Location evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
Parkinson's disease (PD) is increasingly recognized as a multisystem neurodegenerative disorder that extends far beyond its classical motor manifestations. Among its non-motor symptoms, sleep disturbances are among the most prevalent and disabling clinical features, affecting up to 80% of patients and often preceding the onset of motor symptoms by several years. Recent electrophysiological studies have identified the subthalamic nucleus (STN) as a critical hub linking motor dysfunction to sleep abnormalities. Aberrant synchronization of beta (13-30 Hz) oscillations in STN local field potentials (LFPs) persists across wakefulness and sleep, disrupting normal sleep microarchitecture by suppressing slow-wave activity, impairing sleep spindle generation, and destabilizing sleep-stage transitions. These pathological beta oscillations have therefore emerged as a key electrophysiological hallmark of PD-associated sleep dysfunction. Subthalamic deep brain stimulation (STN-DBS), the current standard surgical treatment for advanced PD, has demonstrated significant benefits beyond motor symptom control. Accumulating evidence suggests that STN-DBS improves sleep through multiple complementary mechanisms, including suppression of pathological beta synchronization, restoration of cortico-basal ganglia-thalamocortical network dynamics, modulation of brainstem arousal circuits and neurotransmitter systems, and alleviation of nocturnal motor symptoms. This review summarizes recent advances in the neuroanatomical, electrophysiological, and circuit-level mechanisms linking STN dysfunction to sleep disorders in PD. We further discuss emerging therapeutic strategies and highlight future directions toward biomarker-guided, individualized treatment. Collectively, this review proposes a mechanistic framework linking STN electrophysiology to sleep regulation and identifies testable hypotheses that may facilitate the development of precision neuromodulation strategies for sleep disorders in Parkinson's disease.